0.06% -0.01

Sanofi Adr (SNY)

概要ニュース株価時系列オプションチェーンなぜSNYが下落しているのか？ディスカッション予測株の配当実績

Sanofi Adr (SNY) 最新ニュース

Nov 11, 2025

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION - GlobeNewswire Inc.

Nov 11, 2025

Oct 28, 2025

Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness - Sahm

Oct 28, 2025

Oct 27, 2025

UPDATE - GlobeNewswire Inc.

Oct 27, 2025

Oct 24, 2025

Sanofi ADR earnings beat by $0.72, revenue fell short of estimates - Investing.com Nigeria

Oct 24, 2025

Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark - Sahm

Oct 24, 2025

Oct 22, 2025

Sanofi Drug Shows Superior Efficacy In Genetic Disease Compared To Current Standard Therapy - Sahm

Oct 22, 2025

Oct 17, 2025

Sanofi's Rezurock Approval Stumbles In EU For Chronic Graft-Vs-Host Disease - Sahm

Oct 17, 2025

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times - Sahm

Oct 17, 2025

Oct 16, 2025

Sanofi’s AlphaMedix Achieves Key Efficacy Endpoints in Phase 2 Study - The Globe and Mail

Oct 16, 2025

Sanofi (SNYNF) Gets a Buy from J.P. Morgan - The Globe and Mail

Oct 16, 2025

Oct 14, 2025

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential - Sahm

Oct 14, 2025

Oct 11, 2025

SanofiAmerican Depositary Shares (NQ: SNY - FinancialContent

Oct 11, 2025

Oct 04, 2025

UBS Reaffirms Their Buy Rating on Sanofi (SNYNF) - The Globe and Mail

Oct 04, 2025

Oct 02, 2025

Leerink Partners Sticks to Its Buy Rating for Sanofi (SNYNF) - The Globe and Mail

Oct 02, 2025

Sep 29, 2025

BostInno🗳️ Vote in Inno Madness round two | 💻 UKG announces layoffs - The Business Journals

Sep 29, 2025

Sep 26, 2025

Sanofi Expands Insulin Savings Program To Cover All US Patients - Sahm

Sep 26, 2025

Amgen Expands US Manufacturing Network Amid New Tariff Policy - Sahm

Sep 26, 2025

Sep 17, 2025

Sanofi Reports Early Brivekimig Data, Signals Strong Efficacy And Good Tolerability - Sahm

Sep 17, 2025

Sep 16, 2025

AstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit - Sahm

Sep 16, 2025

Sep 12, 2025

Sanofi: Informations relatives au nombre de droits de vote et d'actions - GlobeNewswire Inc.

Sep 12, 2025

Sep 10, 2025

Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS® - Ariva

Sep 10, 2025

Sep 05, 2025

Leerink Partners Sticks to Their Buy Rating for Sanofi (SNY) - The Globe and Mail

Sep 05, 2025

Sep 04, 2025

PFE

$25.42

1.63%

GILD

$124.58

0.56%

NVO

$48.74

0.83%

AMGN

$337.13

0.09%

MRK

$94.89

2.06%

Sanofi Adr (SNY)

Sanofi Adr (SNY) 最新ニュース

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION - GlobeNewswire Inc.

Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness - Sahm

UPDATE - GlobeNewswire Inc.

Sanofi ADR earnings beat by $0.72, revenue fell short of estimates - Investing.com Nigeria

Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark - Sahm

Sanofi Drug Shows Superior Efficacy In Genetic Disease Compared To Current Standard Therapy - Sahm

Sanofi's Rezurock Approval Stumbles In EU For Chronic Graft-Vs-Host Disease - Sahm

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times - Sahm

Sanofi’s AlphaMedix Achieves Key Efficacy Endpoints in Phase 2 Study - The Globe and Mail

Sanofi (SNYNF) Gets a Buy from J.P. Morgan - The Globe and Mail

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential - Sahm

SanofiAmerican Depositary Shares (NQ: SNY - FinancialContent

UBS Reaffirms Their Buy Rating on Sanofi (SNYNF) - The Globe and Mail

Leerink Partners Sticks to Its Buy Rating for Sanofi (SNYNF) - The Globe and Mail

BostInno🗳️ Vote in Inno Madness round two | 💻 UKG announces layoffs - The Business Journals

Sanofi Expands Insulin Savings Program To Cover All US Patients - Sahm

Amgen Expands US Manufacturing Network Amid New Tariff Policy - Sahm

Sanofi Reports Early Brivekimig Data, Signals Strong Efficacy And Good Tolerability - Sahm

AstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit - Sahm

Sanofi: Informations relatives au nombre de droits de vote et d'actions - GlobeNewswire Inc.

Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS® - Ariva

Leerink Partners Sticks to Their Buy Rating for Sanofi (SNY) - The Globe and Mail

What's Going On With Nektar Therapeutics Stock On Thursday? - Sahm

Why Is Sanofi Stock Falling Thursday? - Sahm

Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors - Sahm

SNYに似た銘柄